Case report highlights neutropenia from febuxostat in patients, suggesting awareness of adverse reaction is crucial.
Neutropenia induced by febuxostat is uncommon, with limited literature available to assess its frequency. This rare complication carries a serious risk to life. It is essential for healthcare providers to stay alert and informed about this potential adverse reaction.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: